A May 13 administrative order from Paul R. Rodríguez, the acting director of the state’s division of consumer affairs, determined a temporary yield on legal requirements that usually prevent pharmacists from administering tests without participating in a collaborative practice agreement or protocol with a physician.
Pharmacists are permitted to perform only tests approved or given an emergency use authorization by the FDA. State officials expect testing will be conducted the most at pharmacy locations with drive-thrus.
“With thousands of pharmacists now authorized to administer COVID-19 tests, finding a testing site in New Jersey will be as easy as walking to the corner drug store,” said the state’s attorney general, Gurbir Grewal, in an announcement on the governor’s website.
New Jersey is slated to test at least 20,000 residents per day by the end of May and 25,000 by the end of June.
More articles on pharmacy:
Trump inks deal to create the nation’s first strategic stockpile of COVID-19 drugs
Gilead to donate 300,000 more remdesivir doses to US hospitals
Moncef Slaoui resigns from Moderna board, divests $10M in stock
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
